On the stock market since 2026, it operates in the everyday-essentials business. It has 153 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
Business Quality: Profit power and business quality trail similar companies in the sector.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades 37% below its peak. The market has trimmed its expectations for the company.
Sales run at $240.7M a year. A small number, but proof the product has real buyers.
The average analyst price target is $20.50 — 26% above today’s price.
A loss of $17.2M against $240.7M in annual sales.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, OFRM sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: OFRM is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (13/100) says the stock isn’t cheap.